Robert E. Gagnon Insider Trades at Opus Genetics ($IRD)

Chief Financial Officer · Opus Genetics, Inc. · Latest filing Oct 23, 2026

Robert E. Gagnon, Chief Financial Officer at Opus Genetics, Inc. has 2 Form 4 trades on file since Jul 23, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($72.59K), net -$72.59K. Latest filing: disposed of 14K shares of $IRD on Oct 23, 2026 at $3.55.

Trades on file

2

Open-market bought

$0

Open-market sold

$72.59K

Net open-market

-$72.59K

Shares held ($IRD)

542.38K

Latest filing

Oct 23, 2026

Shares held by Robert E. Gagnon

• $IRD542.38K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Robert E. Gagnon

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 23, 2026	$IRD	Sell (Open-market sale) 10b5-1	14K	$3.55	$49.65K	542.38K	-2.52%				Chief Financial Officer	SEC	Read
Jul 23, 2026	$IRD	Sell (Open-market sale)	7.78K	$2.95	$22.94K	584.38K	-1.31%	+31.5%	+38.0%		Chief Financial Officer	SEC	—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Robert E. Gagnon traded

• $IRD

Frequently asked questions

Has Robert E. Gagnon been buying or selling stock?

Robert E. Gagnon has 0 open-market purchases and 2 open-market sales on file, net -$72.59K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Robert E. Gagnon's latest insider trade?

disposed of 14K shares of $IRD on Oct 23, 2026 at $3.55.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.